罗莫苏zumab添加到正在进行的denosumab在绝经后骨质疏松症,一个前性观察性研究
Giovanni Adami1, Elisa Pedrollo1, Maurizio Rossini1
1Rheumatology Unit, Department of Medicine, University of Verona, Verona, 37134, Italy.
JBMR plus
|March 28, 2024
概括
罗莫苏祖马布改善了绝经后骨质疏松症患者的骨矿物质密度 (BMD) 和骨形成标志物. 添加romosozumab与denosumab显示有好处,但需要进一步的试验.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 绝经后骨质疏松症 (OP) 管理需要优化顺序和组合治疗.
- 严重的OP的长期治疗策略对于患者的治疗结果至关重要.
研究的目的:
- 为了评估romosozumab的疗效,单独或与denosumab结合,在绝经后的妇女严重的OP.
- 评估骨矿物质密度 (BMD) 和骨周转标记物的变化.
主要方法:
- 6个月的前性观察性研究.
- 包括患有严重OP的绝经后妇女,接受单独罗莫苏马布,罗莫苏马布加登索马布或单独登索马布.
- 测量 BMD,骨周转指标,骨调节器和酸代谢.
主要成果:
- 单独使用罗莫苏祖马布,在所有测量地点显著增加了BMD.
- 罗莫苏zumab与denosumab结合增加腰椎骨质量和骨形成标志物 (P1nP).
- 在罗莫苏祖马布组中,硬质素水平增加;Dkk1水平保持不变.
结论:
- 添加到denosumab的罗莫索祖马布改善了骨形成标记物和腰椎骨质量.
- 罗莫苏祖马布单一治疗显示出显著的BMD增长.
- 进一步的随机对照试验是必要的,以确认发现和评估骨折结果.
相关概念视频
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K


